The Trump HHS banned drug rebates at the last minute, and that final rule is expected to increase premiums early during Biden’s administration, but President Joe Biden’s regulatory freeze lets HHS delay that rule while it’s reconsidered. The Biden administration’s freeze of last-minute Trump administration regulations lets HHS officials determine whether to delay final drug pricing rules that have not taken effect. The freeze could affect both the Trump administration’s ban on drug rebates and a rule that makes health...